ロード中...
Can endolysosomal deacidification and inhibition of autophagy prevent severe COVID-19?
The possibility is examined that immunomodulatory pharmacotherapy may be clinically useful in managing the pandemic coronavirus disease 2019 (COVID-19), known to result from infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a positive-sense single-stranded RNA virus. The...
保存先:
| 出版年: | Life Sci |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier Inc.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7537668/ https://ncbi.nlm.nih.gov/pubmed/33035581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lfs.2020.118541 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|